The 36-month beta value for BSGM is at 0.16. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BSGM is 18.86M, and currently, shorts hold a 2.45% of that float. The average trading volume for BSGM on April 24, 2025 was 280.89K shares.
BSGM) stock’s latest price update
Biosig Technologies Inc (NASDAQ: BSGM) has experienced a rise in its stock price by 12.28 compared to its previous closing price of 0.57. However, the company has seen a gain of 8.47% in its stock price over the last five trading days. globenewswire.com reported 2025-03-26 that Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, is pleased to announce that its common stock will continue trading on The Nasdaq Capital Market (“Nasdaq”).
BSGM’s Market Performance
Biosig Technologies Inc (BSGM) has experienced a 8.47% rise in stock performance for the past week, with a 29.61% rise in the past month, and a -43.86% drop in the past quarter. The volatility ratio for the week is 18.76%, and the volatility levels for the past 30 days are at 17.94% for BSGM. The simple moving average for the past 20 days is 11.67% for BSGM’s stock, with a -24.35% simple moving average for the past 200 days.
BSGM Trading at -10.23% from the 50-Day Moving Average
After a stumble in the market that brought BSGM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.10% of loss for the given period.
Volatility was left at 17.94%, however, over the last 30 days, the volatility rate increased by 18.76%, as shares surge +21.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.96% lower at present.
During the last 5 trading sessions, BSGM rose by +8.47%, which changed the moving average for the period of 200-days by +56.17% in comparison to the 20-day moving average, which settled at $0.5732. In addition, Biosig Technologies Inc saw -57.05% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BSGM
Current profitability levels for the company are sitting at:
- -321.55 for the present operating margin
- -6.35 for the gross margin
The net margin for Biosig Technologies Inc stands at -258.32. The total capital return value is set at 9.05. Equity return is now at value -8041.70, with -782.58 for asset returns.
Based on Biosig Technologies Inc (BSGM), the company’s capital structure generated -0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -46.65. The debt to equity ratio resting at -0.07. The interest coverage ratio of the stock is -1607.75.
Currently, EBITDA for the company is -12.42 million with net debt to EBITDA at 0.0. When we switch over and look at the enterprise to sales, we see a ratio of 387.04. The receivables turnover for the company is 0.37for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.15.
Conclusion
In conclusion, Biosig Technologies Inc (BSGM) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
